Borchardt KA, Zhang MZ, Shing H, Flink K (1997. 8). „A comparison of the sensitivity of the InPouch TV, Diamond's and Trichosel media for detection of Trichomonas vaginalis”. Genitourinary Medicine73 (4), 297-298. o. DOI:10.1136/sti.73.4.297. ISSN0266-4348. PMID 9389954.
Patel SR, Wiese W, Patel SC, Ohl C, Byrd JC, Estrada CA (2000. 1). „Systematic review of diagnostic tests for vaginal trichomoniasis”. Infectious Diseases in Obstetrics and Gynecology8 (5-6), 248-257. o. DOI:10.1155/s1064744900000375. ISSN1064-7449. PMID 11220487.
Wendel KA, Workowski KA (2007. 4). „Trichomoniasis: challenges to appropriate management”. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America44 (Suppl 3), S123-9. o. DOI:10.1086/511425. ISSN1058-4838. PMID 17342665.
Mammen-Tobin A, Wilson JD (2005. 7). „Management of metronidazole-resistant Trichomonas vaginalis – a new approach”. International Journal of STD & AIDS16 (7), 488-490. o. DOI:10.1258/0956462054308422. ISSN0956-4624. PMID 16004628.
Mendling W, Weissenbacher ER, Gerber S, Prasauskas V, Grob P (2015. 10). „Use of locally delivered dequalinium chloride in the treatment of vaginal infections: a review”. Archives of Gynecology and Obstetrics293 (3), 469-484. o. DOI:10.1007/s00404-015-3914-8. ISSN0932-0067. PMID 26506926.
De La Hoz FJE (2019. 6). „Efficacy and tolerance of policresulen in the treatment of the genitourinary syndrome of menopause”. International Journal of Family & Community Medicine3 (3), 132-136. o. DOI:10.15406/ijfcm.2019.03.00145. ISSN2577-8269. „Policresulen has a selective effect on dead or pathologically altered tissues in the vagina, making them coagulate with a subsequent elimination, without affecting the healthy squamous epithelium. Its broad antimicrobial spectrum eradicates the pathogens of the vagina (bacteria, trichomonas and fungi), but increases the growth of Lactobacilli (Bacillus Döderlein) responsible for maintaining the physiological acidity of the vagina.”
Küng E, Pietrzak J, Klaus C, Walochnik J (2016. 1). „In vitro effect of octenidine dihydrochloride against Trichomonas vaginalis”. International Journal of Antimicrobial Agents47 (3), 232-234. o. DOI:10.1016/j.ijantimicag.2015.12.010. ISSN0924-8579. PMID 26899578.
Mercer F, Johnson PJ (2018. 6). „Trichomonas vaginalis: Pathogenesis, symbiont interactions, and host cell immune responses”. Trends in Parasitology34 (8), 683-693. o. DOI:10.1016/j.pt.2018.05.006. ISSN1471-4922. PMID 30056833.
Pavić R, Stojković L (1983. 1). „Vaccination with SolcoTrichovac. Immunological aspects of a new approach for therapy and prophylaxis of trichomoniasis in women”. Gynäkologisch-geburtshilfliche Rundschau23 (Suppl 2), 27–38. o. DOI:10.1159/000269590. ISSN0017-6001. PMID 6629132.
de Weck A (1984. 1). „An explanation of the mode of action of Gynatren/SolcoTrichovac based on immunological considerations”. Gynäkologisch-geburtshilfliche Rundschau24 (Suppl 3), 25–28. o. DOI:10.1159/000269922. ISSN0017-6001. PMID 6537384.
Spiegel CA.szerk.: Honigberg BM: Microflora associated with Trichomonas vaginalis and vaccination against vaginal trichomoniasis, Trichomonads parasitic in humans. Springer, New York, NY, 213–224. o.. DOI: 10.1007/978-1-4612-3224-7_10 (1990). ISBN 978-1-4612-7922-8
Goisis M, Magliano E, Goisis F (1983. 1). „Effects of vaccination with SolcoTrichovac on the vaginal flora and the morphology of the Doederlein bacilli”. Gynäkologisch-geburtshilfliche Rundschau23 (Suppl 2), 56–63. o. DOI:10.1159/000269598. ISSN0017-6001. PMID 6629136.
Harris JRW (1984. 1). „Double-blind comparative study of Trichomonas vaginalis infection: SolcoTrichovac versus placebo”. Gynäkologisch-geburtshilfliche Rundschau24 (Suppl 3), 44–49. o. DOI:10.1159/000269925. ISSN0017-6001. PMID 6399488.
Borchardt KA, Zhang MZ, Shing H, Flink K (1997. 8). „A comparison of the sensitivity of the InPouch TV, Diamond's and Trichosel media for detection of Trichomonas vaginalis”. Genitourinary Medicine73 (4), 297-298. o. DOI:10.1136/sti.73.4.297. ISSN0266-4348. PMID 9389954.
Patel SR, Wiese W, Patel SC, Ohl C, Byrd JC, Estrada CA (2000. 1). „Systematic review of diagnostic tests for vaginal trichomoniasis”. Infectious Diseases in Obstetrics and Gynecology8 (5-6), 248-257. o. DOI:10.1155/s1064744900000375. ISSN1064-7449. PMID 11220487.
Wendel KA, Workowski KA (2007. 4). „Trichomoniasis: challenges to appropriate management”. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America44 (Suppl 3), S123-9. o. DOI:10.1086/511425. ISSN1058-4838. PMID 17342665.
Mammen-Tobin A, Wilson JD (2005. 7). „Management of metronidazole-resistant Trichomonas vaginalis – a new approach”. International Journal of STD & AIDS16 (7), 488-490. o. DOI:10.1258/0956462054308422. ISSN0956-4624. PMID 16004628.
Mendling W, Weissenbacher ER, Gerber S, Prasauskas V, Grob P (2015. 10). „Use of locally delivered dequalinium chloride in the treatment of vaginal infections: a review”. Archives of Gynecology and Obstetrics293 (3), 469-484. o. DOI:10.1007/s00404-015-3914-8. ISSN0932-0067. PMID 26506926.
Küng E, Pietrzak J, Klaus C, Walochnik J (2016. 1). „In vitro effect of octenidine dihydrochloride against Trichomonas vaginalis”. International Journal of Antimicrobial Agents47 (3), 232-234. o. DOI:10.1016/j.ijantimicag.2015.12.010. ISSN0924-8579. PMID 26899578.
Mercer F, Johnson PJ (2018. 6). „Trichomonas vaginalis: Pathogenesis, symbiont interactions, and host cell immune responses”. Trends in Parasitology34 (8), 683-693. o. DOI:10.1016/j.pt.2018.05.006. ISSN1471-4922. PMID 30056833.
Pavić R, Stojković L (1983. 1). „Vaccination with SolcoTrichovac. Immunological aspects of a new approach for therapy and prophylaxis of trichomoniasis in women”. Gynäkologisch-geburtshilfliche Rundschau23 (Suppl 2), 27–38. o. DOI:10.1159/000269590. ISSN0017-6001. PMID 6629132.
de Weck A (1984. 1). „An explanation of the mode of action of Gynatren/SolcoTrichovac based on immunological considerations”. Gynäkologisch-geburtshilfliche Rundschau24 (Suppl 3), 25–28. o. DOI:10.1159/000269922. ISSN0017-6001. PMID 6537384.
Goisis M, Magliano E, Goisis F (1983. 1). „Effects of vaccination with SolcoTrichovac on the vaginal flora and the morphology of the Doederlein bacilli”. Gynäkologisch-geburtshilfliche Rundschau23 (Suppl 2), 56–63. o. DOI:10.1159/000269598. ISSN0017-6001. PMID 6629136.
Harris JRW (1984. 1). „Double-blind comparative study of Trichomonas vaginalis infection: SolcoTrichovac versus placebo”. Gynäkologisch-geburtshilfliche Rundschau24 (Suppl 3), 44–49. o. DOI:10.1159/000269925. ISSN0017-6001. PMID 6399488.
Borchardt KA, Zhang MZ, Shing H, Flink K (1997. 8). „A comparison of the sensitivity of the InPouch TV, Diamond's and Trichosel media for detection of Trichomonas vaginalis”. Genitourinary Medicine73 (4), 297-298. o. DOI:10.1136/sti.73.4.297. ISSN0266-4348. PMID 9389954.
Patel SR, Wiese W, Patel SC, Ohl C, Byrd JC, Estrada CA (2000. 1). „Systematic review of diagnostic tests for vaginal trichomoniasis”. Infectious Diseases in Obstetrics and Gynecology8 (5-6), 248-257. o. DOI:10.1155/s1064744900000375. ISSN1064-7449. PMID 11220487.
Wendel KA, Workowski KA (2007. 4). „Trichomoniasis: challenges to appropriate management”. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America44 (Suppl 3), S123-9. o. DOI:10.1086/511425. ISSN1058-4838. PMID 17342665.
Mammen-Tobin A, Wilson JD (2005. 7). „Management of metronidazole-resistant Trichomonas vaginalis – a new approach”. International Journal of STD & AIDS16 (7), 488-490. o. DOI:10.1258/0956462054308422. ISSN0956-4624. PMID 16004628.
Mendling W, Weissenbacher ER, Gerber S, Prasauskas V, Grob P (2015. 10). „Use of locally delivered dequalinium chloride in the treatment of vaginal infections: a review”. Archives of Gynecology and Obstetrics293 (3), 469-484. o. DOI:10.1007/s00404-015-3914-8. ISSN0932-0067. PMID 26506926.
De La Hoz FJE (2019. 6). „Efficacy and tolerance of policresulen in the treatment of the genitourinary syndrome of menopause”. International Journal of Family & Community Medicine3 (3), 132-136. o. DOI:10.15406/ijfcm.2019.03.00145. ISSN2577-8269. „Policresulen has a selective effect on dead or pathologically altered tissues in the vagina, making them coagulate with a subsequent elimination, without affecting the healthy squamous epithelium. Its broad antimicrobial spectrum eradicates the pathogens of the vagina (bacteria, trichomonas and fungi), but increases the growth of Lactobacilli (Bacillus Döderlein) responsible for maintaining the physiological acidity of the vagina.”
Küng E, Pietrzak J, Klaus C, Walochnik J (2016. 1). „In vitro effect of octenidine dihydrochloride against Trichomonas vaginalis”. International Journal of Antimicrobial Agents47 (3), 232-234. o. DOI:10.1016/j.ijantimicag.2015.12.010. ISSN0924-8579. PMID 26899578.
Mercer F, Johnson PJ (2018. 6). „Trichomonas vaginalis: Pathogenesis, symbiont interactions, and host cell immune responses”. Trends in Parasitology34 (8), 683-693. o. DOI:10.1016/j.pt.2018.05.006. ISSN1471-4922. PMID 30056833.
Újhelyi Károly, Philipp György, Plank György, Sági Tamás (1973). „A trichomonas syndroma”. Magyar Nőorvosok Lapja36, 433–442. o. ISSN0025-021X.
Pavić R, Stojković L (1983. 1). „Vaccination with SolcoTrichovac. Immunological aspects of a new approach for therapy and prophylaxis of trichomoniasis in women”. Gynäkologisch-geburtshilfliche Rundschau23 (Suppl 2), 27–38. o. DOI:10.1159/000269590. ISSN0017-6001. PMID 6629132.
de Weck A (1984. 1). „An explanation of the mode of action of Gynatren/SolcoTrichovac based on immunological considerations”. Gynäkologisch-geburtshilfliche Rundschau24 (Suppl 3), 25–28. o. DOI:10.1159/000269922. ISSN0017-6001. PMID 6537384.
Goisis M, Magliano E, Goisis F (1983. 1). „Effects of vaccination with SolcoTrichovac on the vaginal flora and the morphology of the Doederlein bacilli”. Gynäkologisch-geburtshilfliche Rundschau23 (Suppl 2), 56–63. o. DOI:10.1159/000269598. ISSN0017-6001. PMID 6629136.
Harris JRW (1984. 1). „Double-blind comparative study of Trichomonas vaginalis infection: SolcoTrichovac versus placebo”. Gynäkologisch-geburtshilfliche Rundschau24 (Suppl 3), 44–49. o. DOI:10.1159/000269925. ISSN0017-6001. PMID 6399488.